Miragen Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $127k | 9.8k | 13.00 |
| 2024-03-31 | $19k | 1.1k | 17.51 |
| 2023-09-30 | $140k | 9.2k | 15.34 |
| 2023-06-30 | $118k | 5.0k | 23.79 |
| 2023-03-31 | $83k | 3.2k | 25.67 |
| 2022-12-31 | $5.0k | 163 | 30.67 |
| 2022-09-30 | $167k | 8.2k | 20.48 |
| 2022-06-30 | $33k | 2.8k | 11.67 |
| 2022-03-31 | $45k | 2.5k | 18.28 |
| 2021-12-31 | $0 | 1 | 0.00 |
| 2021-03-31 | $2.0k | 118 | 16.95 |